e+CancerCare completes majority recapitalization
June 06, 2011
Frontenac has recapitalized in e+CancerCare in partnership with a new investor. e+CancerCare is a leading provider of outpatient cancer services through partnerships with local hospitals and physicians. Frontenac retains a significant minority stake in the company and believes it is poised for continued growth organically and through acquisitions as its sector consolidates.